The following table shows the computation of basic and diluted net income per common share for the three and nine months ended March 31, 2025 and 2024 (in thousands, except per share amounts):


	Three Months Ended March 31,				Nine Months Ended March 31,
	2025		2024		2025		2024
Numerator:
Net income - basic	$	108,777	$	402,459	$	853,700	$	855,422
Convertible Notes interest charge, net of tax	—		385		1,777		385
Net income - diluted	$	108,777	$	402,844	$	855,477	$	855,807

Denominator:
Weighted-average shares outstanding - basic	595,041		564,780		592,349		545,620
Effect of dilutive convertible notes	—		4,710		1,673		1,550
Effect of dilutive securities	26,768		44,820		31,250		41,720
Weighted-average shares outstanding - diluted	621,809		614,310		625,272		588,890

Net income per common share - basic	$	0.18	$	0.71	$	1.44	$	1.57
Net income per common share - diluted	$	0.17	$	0.66	$	1.37	$	1.45

Potentially dilutive shares of common stock issuable upon conversion of the Company's outstanding 3.50% Convertible Senior Notes (as amended, restated, and/or otherwise modified from time to time, the “2029 Convertible Notes”), and outstanding 2.25% 2028 Convertible Senior Notes (the “2028 Convertible Notes”) are determined using the if-converted method. For the nine months ended March 31, 2025, shares issuable upon conversion of the 2028 Convertible Notes were dilutive and were included within the numerator for interest and denominator for shares issuable upon conversion of the diluted net income per common share computation. For three months ended March 31, 2025, shares issuable upon conversion of 2028 Convertible Notes were anti-dilutive. For three and nine months ended March 31, 2025, shares issuable upon conversion of 2029 Convertible Notes were anti-dilutive.

The following table presents the potentially dilutive shares that were excluded from the computation of diluted net income per share of common shares attributable to common stockholders, because their effect was anti-dilutive (in thousands):